Authors

  • Ташкенбаева Н.Ф., Курбанов Р.Д.

Keywords:

хроническая сердечная недостаточность, толерантность к нагрузке, ожирение, качество жизни, SF-36, MLHFQ, метаболический синдром.

References

1. Angius L, Deiana M, Corona C, et al. Exercise intolerance and fatigue in chronic heart failure: the role of muscle afferents. Front Physiol. 2020 ;11 :590529. doi :10.3389/fphys.2020.590529. https:// www.ncbi.nlm.nih.gov/pmc/articles/PMC7672669/ PMC

2. Arena R, Myers J, Gulati M, et al. Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association. Circulation. 2007;116(3):329-343. doi:10.1161/CIRCULATIONAHA.106.185461.

3. Brubaker PH, Kitzman DW. Chronotropic incompetence: causes, consequences, and management. Circulation. 2011;123(9):1010-1020. doi:10. 1161/circulationaha.110.954463.

4. Cittadini A, Iacoviello M, L’Abbate A. Multiple hormonal and metabolic deficiency syndrome in chronic heart failure. Eur J Prev Cardiol. 2021;28 (15):1691-1703. doi:10.1093/eurjpc/erab024.

5. Del Buono MG, Arena R, Borlaug BA, Carbone S, Canada JM, Kirkman DL, et al. Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;73(17):2209-2225. doi: 10.1016/j.jacc.2019.01.072. https://doi. org/10.1016/j.jacc.2019.01.072

6. Huang ZM, Chen WR, Su QW, Huang ZW. Prognostic Impact of Metabolic Syndrome in Patients With Heart Failure: A Meta-Analysis of Observational Studies. Front Cardiovasc Med. 2021; 8:704446. doi: 10.3389/fcvm.2021.704446. https://www.frontier-sin.org/articles/10.3389/fcvm.2021.704446/full

7. Kitzman DW, Brubaker PH, Morgan TM, Stewart KP, Little WC. Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. Circ Heart Fail. 2010;3(6):659-667. doi:10.1161/circhea-rtfailure.110.958785.

8. Laurent S, Boutouyrie P. Arterial stiffness and hypertension in the elderly. Hypertension. 2007; 49(4):620-628. doi: 10.1161/01.HYP.0000250409. 60225.47.

9. Luo X, Chen L, Wang L, et al. Association between cardiometabolic index and congestive heart failure: evidence from NHANES 1999-2018. Cardiol Res Pract. 2024;2024: Article ID 145678. doi:10. 11 55/2024/145678. https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC11419996/

10. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36):3599-3726. doi:10.1093/eurheartj/ehab368

11. Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020;383(15):1413-1424. doi:10.1056/NEJ Moa2022190.

12. Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263-271. doi:10.1016/j.jacc.2013.02.092.

13. Piepoli MF, Conraads V, Corrà U, Dickstein K, Francis DP, Jaarsma T, et al. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail. 2011;13(4):347-357. doi:10.1093/eurjhf/hfr017.

14. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J. 1992;124(4):1017-1025. doi:10.1016/0002-8703(92)90986-6.

15. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure Questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J. 1992;124(4):1017-1025.

16. Shah SJ, Kitzman DW, Borlaug BA, et al. Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation. 2016;134(1):73-90. doi:10.1161/circu-lationaha.116.021884.

17. Taylor RS, Walker S, Smart NA, Piepoli MF, Warren FC, Ciani O, et al. Exercise-based cardiac rehabilitation for chronic heart failure: Cochrane systematic review and meta-analysis. BMJ. 2019;364: l166. doi:10.1136/bmj. l166.

18. Triposkiadis F, Xanthopoulos A, Butler J. Pathophysiology of chronic heart failure: neurohumoral, hemodynamic, and structural mechanisms. Heart Fail Rev. 2019;24(2):167-180. doi:10.1007/ s10741-018-9714-0.

19. Van der Vaart H, Karagiannis D, Dijk DJ, et al. Chronotropic Incompetence: Pathophysiology and Clinical Implications. J Cardiovasc Transl Res. 2020;13(3):285-296. doi:10.1007/s12265-020-100 21-0.

20. Ware JE Jr, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992; 30(6):473-483. doi:10.1097/00005650-199206000 -00002.

21. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30 (6):473-483. doi:10.1097/00005650-199206000-0 0002.

22. Xie Q, Li Q, Liu J, et al. Predictive Effect of Alternative Insulin Resistance Indexes for the Risk of Heart Failure in Patients with Metabolic Syndrome. Diabetes Metab Syndr Obes. 2024;17:457–468. doi: 10.2147/DMSO.S457598.

23. Yoon HJ, Ahn Y, Kim KH, Park JC, Choi DJ, Han S, et al. The prognostic implication of metabolic syndrome in patients with heart failure. Korean Circ J. 2013;43(2):87-92. doi:10.4070/kcj.2013.43.2.87. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596669/

24. Zannad F, Ferreira JP, Pocock SJ, Anker SD, Butler J, Filippatos G, et al. Exercise capacity and outcomes in chronic heart failure: mechanisms and management. Lancet. 2019;393(10188):1077-1087. doi:10.1016/S0140-6736(18)33132-1.

25. Zhu Z, Liu Y, Zhang C, Yuan Z, Zhang Q, Tang F, et al. Identification of Cardiovascular Risk Components in Urban Chinese with Metabolic Syndrome and Application to Coronary Heart Disease Prediction: A Longitudinal Study. PLoS ONE. 2013;8 (12): e84204. doi:10.1371/journal. pone.0084204.